DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
Companies / T••••••••• T••••••••• I•••
T••••••••• T••••••••• I•••
Stage unknownCambridge, MABiotechnology
Facts
Financing history
1 round
- Jan 8, 2026Form D equity offering · $56.3M (form d sold) · 6 investorsFact Form D · “••• Locked”
Investors on record
1 edge
- R• C•••••• M••••••••• L• board only, L•••• T•••••••• (strongly supported) Inference sec.gov
People
1 officer, 3 directors
- M•••••• S•••••• Executive Officer/Director sec.gov
- K•••••• H•••• Director Fact
- L•••• T•••••••• Director Inference
- M••••• D•••••• Director Fact
Timeline
1
- Sep 21, 2026••• LockedForm D filed Fact Form D
Evidence
15 observations
Every observation on this company
- Entity type: Corporation Sep 21, 2026 Fact Form D
- Form D industry group: Biotechnology Sep 21, 2026 Fact Form D
- Amendment: false Sep 21, 2026 Fact Form D
- Revenue range (Form D): Decline to Disclose Sep 21, 2026 Fact Form D
- Incorporated: withinFiveYears Sep 21, 2026 Fact Form D
- Jurisdiction: Delaware Sep 21, 2026 Fact Form D
- Amount sold (Form D): $56.3M Sep 21, 2026 Fact Form D
- Offering amount (Form D): $56.3M Sep 21, 2026 Fact Form D
- Exemptions: 06b Sep 21, 2026 Fact Form D
- First sale: 2026-01-08 Sep 21, 2026 Fact Form D
- Investors (Form D): 6 Sep 21, 2026 Fact Form D
- Minimum investment (Form D): 0 Sep 21, 2026 Fact Form D
- Securities offered: equity Sep 21, 2026 Fact Form D
- Office address: ••• Locked Sep 21, 2026 Fact Form D
- Year of incorporation: 2022 Sep 21, 2026 Fact Form D